↓ Skip to main content

Cochrane Database of Systematic Reviews

Once-daily long-acting beta₂-agonists/inhaled corticosteroids combined inhalers versus inhaled long-acting muscarinic antagonists for people with chronic obstructive pulmonary disease

Overview of attention for article published in Cochrane database of systematic reviews, August 2018
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (83rd percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
22 tweeters
facebook
2 Facebook pages

Citations

dimensions_citation
6 Dimensions

Readers on

mendeley
147 Mendeley
Title
Once-daily long-acting beta₂-agonists/inhaled corticosteroids combined inhalers versus inhaled long-acting muscarinic antagonists for people with chronic obstructive pulmonary disease
Published in
Cochrane database of systematic reviews, August 2018
DOI 10.1002/14651858.cd012355.pub2
Pubmed ID
Authors

Agnieszka Sliwka, Milosz Jankowski, Iwona Gross-Sondej, Monika Storman, Roman Nowobilski, Malgorzata M Bala

Twitter Demographics

The data shown below were collected from the profiles of 22 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 147 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 147 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 25 17%
Student > Bachelor 20 14%
Student > Ph. D. Student 14 10%
Researcher 11 7%
Other 9 6%
Other 23 16%
Unknown 45 31%
Readers by discipline Count As %
Medicine and Dentistry 40 27%
Nursing and Health Professions 26 18%
Pharmacology, Toxicology and Pharmaceutical Science 10 7%
Economics, Econometrics and Finance 6 4%
Psychology 6 4%
Other 13 9%
Unknown 46 31%

Attention Score in Context

This research output has an Altmetric Attention Score of 13. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 November 2018.
All research outputs
#1,642,833
of 16,109,166 outputs
Outputs from Cochrane database of systematic reviews
#4,179
of 11,405 outputs
Outputs of similar age
#44,635
of 278,183 outputs
Outputs of similar age from Cochrane database of systematic reviews
#80
of 161 outputs
Altmetric has tracked 16,109,166 research outputs across all sources so far. Compared to these this one has done well and is in the 89th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 11,405 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 23.8. This one has gotten more attention than average, scoring higher than 63% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 278,183 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 83% of its contemporaries.
We're also able to compare this research output to 161 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 50% of its contemporaries.